| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |